Cargando…
Tuberculosis and antimicrobial resistance – new models of research and development needed
Autores principales: | Brigden, Grania, Castro, José Luis, Ditiu, Lucica, Gray, Glenda, Hanna, Debra, Low, Marcus, Matsoso, Malebona Precious, Perry, Greg, Spigelman, Melvin, Swaminathan, Souyma, Torreele, Els, Wong, Sidney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418818/ https://www.ncbi.nlm.nih.gov/pubmed/28479629 http://dx.doi.org/10.2471/BLT.17.194837 |
Ejemplares similares
-
Business-as-Usual will not Deliver the COVID-19 Vaccines We Need
por: Torreele, Els
Publicado: (2020) -
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
por: Brigden, Grania, et al.
Publicado: (2015) -
Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets
por: Sahu, Suvanand, et al.
Publicado: (2021) -
The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs
por: Farlow, Andrew, et al.
Publicado: (2023) -
COVID-19 vaccines: effectiveness and number needed to treat – Authors' reply
por: Olliaro, Piero, et al.
Publicado: (2021)